EQA of malignant mesothelioma marker analyses.

Dr. Mogens Vyberg graduated in 1973, completed residencies in Anatomic and Clinical Pathology at hospitals associated with University of Copenhagen, and was board-certified 1984. Since 1988 he has been senior consultant at the Institute of Pathology, Aalborg Hospital and was appointed as professor of clinical pathology at Aalborg University in 2012. Dr. Vyberg’s main research … Continúa leyendo EQA of malignant mesothelioma marker analyses.

Malignant mesothelioma – update on pathology and IHC.

Sisko Liisa Anttila.   Dr. Sisko Anttila, MD, PhD, is Head of the Jorvi Hospital Laboratory of Pathology at Helsinki University Hospital and HUSLAB, Espoo, Finland. Previously, between 1988 and 2007 (until 2014 part-time) she worked as chief physician and pathologist at the Finnish Institute of Occupational Health, Helsinki, Finland, and as visiting scientist at the … Continúa leyendo Malignant mesothelioma – update on pathology and IHC.

Malignant mesothelioma – epidemiology and molecular biology.

Dr. Oluf Dimitri Røe.   Specialist in Oncology (Medical and Radiation Oncology) 2007 PhD Dissertation 2008 Faculty of Medicine, NTNU, Title of Thesis: Malignant mesothelioma: Virus, Biomarkers and Genes. A Translational Approach Brief Scientific profile My main research interests have been a combination of clinical and basic cancer research (translational), including biomarkers for early detection of … Continúa leyendo Malignant mesothelioma – epidemiology and molecular biology.

EQA of lung carcinoma analyses.

Dr. Mogens Vyberg graduated in 1973, completed residencies in Anatomic and Clinical Pathology at hospitals associated with University of Copenhagen, and was board-certified 1984. Since 1988 he has been senior consultant at the Institute of Pathology, Aalborg Hospital and was appointed as professor of clinical pathology at Aalborg University in 2012. Dr. Vyberg’s main research … Continúa leyendo EQA of lung carcinoma analyses.

2nd NordiQC Conference on Applied Immunohistochemistry.

La segunda conferencia sobre inmunohistoquímica aplicada NordiQC se llevó acabo entre los días 9 y 12 de junio de 2015 en el Europe Hall del Aalborg Congress & Culture Centre, Aalborg, Dinamarca.  A continuación se presenta el programa desarrollado con sus respectivos abstracts. idioma: Inglés. Tuesday 9th June 2015. 16:00  Registration. 18:00 Informal get-together buffet. … Continúa leyendo 2nd NordiQC Conference on Applied Immunohistochemistry.

WHO classification of lung carcinomas 2015.

Keith Kerr has been a Consultant Pathologist in Aberdeen since 1989, after under and post-graduate training in Edinburgh. He was awarded an Honorary Chair in Pulmonary Pathology at the University of Aberdeen in 2006. His research interests include pre-neoplasia and carcinogenesis, lung tumour diagnosis and classification, and the identification of predictors of therapy response. He … Continúa leyendo WHO classification of lung carcinomas 2015.

Atención Evento Cancelado. SOMLA 2018.

ATENCIÓN. IMPORTANTE. EVENTO CANCELADO. Desde la página oficial del 1er Simposio Latinoamericano de Oncología Molecular (http://www.somla.es/) se informa:   “Por razones ajenas a la organización, el Simposio de Oncología Molecular Latinoamericano (SOMLA) no va a poder realizarse en marzo 2018 como estaba previsto. Esperamos que SOMLA pueda ver la luz en un futuro y nos … Continúa leyendo Atención Evento Cancelado. SOMLA 2018.